Back
Eagle Pharmaceuticals Vs. Leidos Holdings Industry Stock Comparison
Sell
17
EGRX
Eagle Pharmaceuticals
Last Price:
0.71
Seasonality Move:
-6.88%
Sell
40
LDOS
Leidos Holdings
Last Price:
158.37
Seasonality Move:
2.48%
Sell
17
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy, Sell or Hold?
- The current Eagle Pharmaceuticals [EGRX] share price is $0.70. The Score for EGRX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- EGRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Leidos Holdings (LDOS)
is a Sell
Is Leidos Holdings a Buy, Sell or Hold?
- The current Leidos Holdings [LDOS] share price is $167.96. The Score for LDOS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- LDOS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EGRX Stock Price Chart
What is Eagle Pharmaceuticals's stock price today?
-
The Eagle Pharmaceuticals share price today is $0.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EGRX is experiencing selling pressure, which indicates risk of future bearish movement.
LDOS Stock Price Chart
What is Leidos Holdings's stock price today?
-
The Leidos Holdings share price today is $167.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LDOS is experiencing selling pressure, which indicates risk of future bearish movement.
EGRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 38.76 | Sell |
| Chaikin Money Flow: | -85095 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.53 - 0.83) | Buy |
| Bollinger Bands (100): | (1.57 - 5.49) | Sell |
LDOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.47 | Buy |
| Relative Strength Index (14 RSI): | 38.92 | Sell |
| Chaikin Money Flow: | -4188569 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (166.87 - 191.75) | Sell |
| Bollinger Bands (100): | (144.85 - 173.49) | Buy |
EGRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.81 | Sell |
| 20-day SMA: | 0.68 | Buy |
| 50-day SMA: | 2.01 | Sell |
| 200-day SMA: | 4.22 | Sell |
| 8-day EMA: | 0.76 | Sell |
| 20-day EMA: | 0.88 | Sell |
| 50-day EMA: | 1.79 | Sell |
| 200-day EMA: | 4.99 | Sell |
LDOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 192.54 | Sell |
| 20-day SMA: | 182.33 | Sell |
| 50-day SMA: | 169.14 | Sell |
| 200-day SMA: | 146.05 | Buy |
| 8-day EMA: | 188.31 | Sell |
| 20-day EMA: | 183.52 | Sell |
| 50-day EMA: | 172.61 | Sell |
| 200-day EMA: | 148.04 | Buy |
Eagle Pharmaceuticals Earnings Growth & EGRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
Leidos Holdings Earnings Growth & LDOS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.05 per share, and an increase next year of $0.31 per share.
Eagle Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Leidos Holdings Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||